Gene · 6752
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With Glioma. | Front Genet | 2022 | 35719378 | PubTator, text mining | PubMed |
| A case of strongly suspected Lynch syndrome with colorectal neuroendocrine carcinoma. | Surg Case Rep | 2022 | 35713748 | PubTator, text mining | PubMed |
| Temozolomide and Capecitabine Treatment for an Aggressive Somatotroph Pituitary Tumor: A Case Report and Literature Review. | Front Oncol | 2022 | 35712496 | PubTator, text mining | PubMed |
| Peptide Receptor Radionuclide Therapy in Thyroid Cancer. | Front Endocrinol (Lausanne) | 2022 | 35712243 | PubTator, text mining | PubMed |
| Differences in tumor-to-normal organ SUV ratios measured with 68 Ga-DOTATATE PET compared with 177 Lu-DOTATATE SPECT in patients with neuroendocrine tumors. | Nucl Med Commun | 2022 | 35703269 | PubTator, text mining | PubMed |
| Comparison of [18F]DOPA and [68Ga]DOTA-TOC as a PET imaging tracer before peptide receptor radionuclide therapy. | Eur J Hybrid Imaging | 2022 | 35701566 | PubTator, text mining | PubMed |
| Unusual Presentation and Surgical Treatment of a Phosphaturic Mesenchymal Tumor in a Knee. | Front Surg | 2022 | 35693311 | PubTator, text mining | PubMed |
| The New Radiolabeled Peptide 99mTcEDDA/HYNIC-TOC: Is It a Feasible Choice for Diagnosing Gastroenteropancreatic NETs? | Cancers (Basel) | 2022 | 35681704 | PubTator, text mining | PubMed |
| Paraganglioma of the urinary bladder initially diagnosed as gastrointestinal stromal tumor requiring combined resection of the rectum: a case report. | World J Surg Oncol | 2022 | 35676716 | PubTator, text mining | PubMed |
| Correlation of somatostatin receptor PET/CT imaging features and immunohistochemistry in neuroendocrine tumors of the lung: a retrospective observational study. | Eur J Nucl Med Mol Imaging | 2022 | 35674739 | PubTator, text mining | PubMed |
| Primary pulmonary meningioma: A case report and review of the literature. | World J Clin Cases | 2022 | 35665099 | PubTator, text mining | PubMed |
| Evaluating diagnostic accuracy and determining optimal diagnostic thresholds of different approaches to [68Ga]-DOTATATE PET/MRI analysis in patients with meningioma. | Sci Rep | 2022 | 35661809 | PubTator, text mining | PubMed |
| Molecular imaging phenotyping for selecting and monitoring radioligand therapy of neuroendocrine neoplasms. | Cancer Imaging | 2022 | 35659779 | PubTator, text mining | PubMed |
| A prospective head-to-head comparison of 68 Ga-NOTA-3P-TATE-RGD and 68 Ga-DOTATATE in patients with gastroenteropancreatic neuroendocrine tumours. | Eur J Nucl Med Mol Imaging | 2022 | 35657429 | PubTator, text mining | PubMed |
| Somatostatin Receptor-negative and Fluorodeoxyglucose-positron Emission Tomography-positive Lung Neuroendocrine Tumor G1 Exhibiting Cyclic Cushing's Syndrome. | Intern Med | 2022 | 35650126 | PubTator, text mining | PubMed |
| Data mining analyses for precision medicine in acromegaly: a proof of concept. | Sci Rep | 2022 | 35643771 | PubTator, text mining | PubMed |
| Necrolytic migratory erythema is an important visual cutaneous clue of glucagonoma. | Sci Rep | 2022 | 35641533 | PubTator, text mining | PubMed |
| Emerging concepts in designing next-generation multifunctional nanomedicine for cancer treatment. | Biosci Rep | 2022 | 35638450 | PubTator, text mining | PubMed |
| Current status and future of targeted peptide receptor radionuclide positron emission tomography imaging and therapy of gastroenteropancreatic-neuroendocrine tumors. | World J Gastroenterol | 2022 | 35633909 | PubTator, text mining | PubMed |
| Somatostatin signalling promotes the differentiation of rod photoreceptors in human pluripotent stem cell-derived retinal organoid. | Cell Prolif | 2022 | 35633292 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6752/papers?page=50